About Oncodna sa
OncoDNA SA: Revolutionizing Cancer Treatment through Personalized Medicine
OncoDNA SA is a leading biotech company that specializes in the field of personalized medicine for cancer patients. The company was founded in 2012 by Jean-Pol Detiffe, a renowned molecular biologist and entrepreneur, with the aim of providing innovative solutions to improve cancer diagnosis and treatment.
OncoDNA's mission is to empower healthcare providers, patients, and their families with advanced genomic testing technologies that enable personalized treatment plans based on each patient's unique genetic profile. The company offers a wide range of services that cater to different stakeholders in the healthcare industry, including hospitals, clinics, research institutions, pharmaceutical companies, and individual patients.
Healthcare Providers:
OncoDNA provides healthcare providers with state-of-the-art genomic testing services that help them make informed decisions about cancer diagnosis and treatment. The company's comprehensive portfolio includes DNA sequencing tests for solid tumors and hematological malignancies as well as liquid biopsy tests for monitoring disease progression and response to therapy.
Moreover, OncoDNA offers an integrated platform called OncoKDM (Knowledge Database Management) that enables physicians to access relevant clinical data from various sources such as medical literature databases or electronic health records (EHRs). This platform helps doctors interpret complex genomic data more efficiently and accurately while also facilitating collaboration among multidisciplinary teams involved in patient care.
Patients & Relatives:
For patients diagnosed with cancer or their relatives seeking information about genetic predisposition to certain types of cancers or hereditary syndromes associated with increased risk of developing cancer later in life; OncoDNA provides personalized genetic counseling services. These services are designed to help individuals understand their risk factors better so they can make informed decisions about preventive measures such as lifestyle changes or screening programs.
Pharma:
OncoDNA collaborates closely with pharmaceutical companies worldwide by providing them access to its extensive database of genomic profiles obtained from thousands of cancer patients worldwide. This database helps pharma companies identify potential drug targets and develop more effective cancer therapies that target specific genetic mutations or biomarkers.
Academia:
OncoDNA also works closely with academic institutions to advance research in the field of personalized medicine for cancer. The company provides researchers with access to its genomic database, bioinformatics tools, and expertise in data analysis. This collaboration helps accelerate the discovery of new biomarkers and therapeutic targets for various types of cancers.
In conclusion, OncoDNA is a game-changer in the field of personalized medicine for cancer patients. Its innovative solutions have already helped thousands of patients worldwide receive more accurate diagnoses and targeted treatments based on their unique genetic profiles. With its commitment to advancing research and collaboration across different stakeholders in the healthcare industry, OncoDNA is poised to revolutionize cancer treatment as we know it today.